Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]
Lead multiple myeloma candidate enters Cohort 8; second asset dosed [...]
Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]
Lead multiple myeloma candidate enters Cohort 8; second asset dosed [...]